Evidence that newer type 2 diabetes therapies offer cardiovasular and renal benefits offer opportunities for greater collaboration among specialists and more value for patients. Payers must take notice.
From the Adult Diabetes and Clinical Research Sections, Joslin Diabetes Center, Harvard Medical School. Approved May 10, 2016; updated April 24, 2018.
For the Figure and Tables, download the PDF at the end of the chapter.
From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts.
This guideline was revised and approved May 17, 2017, and updated February 7, 2018.
Listed below are members of the Clinical Oversight Committee and Working Groups who participated in development of the Clinical Guidelines for Joslin Diabetes Center. Faculty who participated in guideline development who are no longer at Joslin are designated with an asterisk.